Article info
Basic and translational research
Extended report
BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease
- Correspondence to Professor Lorenzo Dagna, Unit of Medicine and Clinical Immunology, San Raffaele Scientific Institute, Via Olgettina 60, Milan 20132, Italy; lorenzo.dagna{at}unisr.it
Citation
BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease
Publication history
- Received November 15, 2013
- Revised March 5, 2014
- Accepted March 6, 2014
- First published March 26, 2014.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions